Altimmune Inc (ALT)
8.01
-0.89
(-10.00%)
USD |
NASDAQ |
May 17, 16:00
8.01
0.00 (0.00%)
After-Hours: 20:00
Altimmune Free Cash Flow (Quarterly): -16.36M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -16.36M |
December 31, 2023 | -16.53M |
September 30, 2023 | -20.49M |
June 30, 2023 | -19.38M |
March 31, 2023 | -19.46M |
December 31, 2022 | -17.34M |
September 30, 2022 | -15.11M |
June 30, 2022 | -16.72M |
March 31, 2022 | -13.54M |
December 31, 2021 | -22.12M |
September 30, 2021 | -17.89M |
June 30, 2021 | -26.70M |
March 31, 2021 | -23.84M |
December 31, 2020 | -13.43M |
September 30, 2020 | -9.584M |
June 30, 2020 | -7.253M |
March 31, 2020 | -4.385M |
December 31, 2019 | -2.004M |
September 30, 2019 | -2.436M |
June 30, 2019 | -3.073M |
March 31, 2019 | -2.117M |
December 31, 2018 | -5.164M |
September 30, 2018 | -1.191M |
June 30, 2018 | 0.1765M |
March 31, 2018 | -4.226M |
Date | Value |
---|---|
December 31, 2017 | -4.835M |
September 30, 2017 | -4.282M |
June 30, 2017 | -7.864M |
March 31, 2017 | -3.400M |
December 31, 2016 | -1.534M |
September 30, 2016 | -2.013M |
June 30, 2016 | -1.671M |
March 31, 2016 | -1.355M |
December 31, 2015 | -1.847M |
September 30, 2015 | -1.339M |
June 30, 2015 | 2.632M |
March 31, 2015 | -2.749M |
December 31, 2014 | -3.522M |
September 30, 2014 | -2.137M |
June 30, 2014 | -0.5755M |
March 31, 2014 | -2.331M |
December 31, 2013 | -6.256M |
September 30, 2013 | -0.6907M |
June 30, 2013 | -0.5405M |
March 31, 2013 | 0.2349M |
December 31, 2012 | -2.145M |
September 30, 2012 | 1.734M |
June 30, 2012 | -2.704M |
March 31, 2012 | 0.7914M |
December 31, 2011 | -0.8051M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-26.70M
Minimum
Jun 2021
-2.004M
Maximum
Dec 2019
-14.38M
Average
-16.44M
Median
Free Cash Flow (Quarterly) Benchmarks
Eli Lilly and Co | 83.20M |
Amgen Inc | 459.00M |
Pfizer Inc | 386.00M |
Viking Therapeutics Inc | -6.134M |
GlycoMimetics Inc | -10.52M |